Natural T-cell responses against minor histocompatibility antigen (mHag) HY following HLA-matched hematopoietic cell transplantation: What are the requirements for a 'good' mHag?

Leukemia

Volumn 22, Issue 10, 2008, Pages 1948-1951

  Kollgaard, T ^a   Hadrup, S Reker ^a   Petersen, S L ^b   Masmas, T N ^b   Andersen, M H ^a   Spierings, E ^c   Vindelov L ^b   thor Straten, P ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN HY; UNCLASSIFIED DRUG;

ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLONAL VARIATION; COCULTURE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENOTYPE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIBLING; T LYMPHOCYTE;

EID: 54049143278     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.75     Document Type: Article

References (22)

1. Sorror ML, Storer BE, Maloney DG, Sandmaier BM, Martin PJ, Storb R. Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia. Blood 2007; 111: 446-452.
2. Dickinson AM, Wang XN, Sviland L, Vyth-Dreese FA, Jackson GH, Schumacher TN et al. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med 2002; 8: 410-414.
3. Spierings E, Wieles B, Goulmy E. Minor histocompatibility antigens - big in tumour therapy. Trends Immunol 2004; 25: 56-60.
4. Hambach L, Goulmy E. Immunotherapy of cancer through targeting of minor histocompatibility antigens. Curr Opin Immunol 2005; 17: 202-210.
5. Minor Histocompatibility Knowledge Database; dbMinor (http://www.lumc.nl/ 5033/dbminor/), accessed 20 March 2008.
6. Spierings E, Hendriks M, Absi L, Canossi A, Chhaya S, Crowley J et al Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations. PLoS Genet 2007; 3: E103.
7. Meadows LM, Wang W, den Haan JM, Blokland E, Reinhardus C, Drijfhout JW et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 1997; 6: 273-281.
8. Takami A, Sugimori C, Feng X, Yachie A, Kondo Y, Nishimura R et al Expansion and activation of minor histocompatibility antigen HY-specific T cells associated with graft-versus-leukemia response. Bone Marrow Transplant 2004; 34: 703-709.
9. Robertson NJ, Chai JG, Millrain M, Scott D, Hashim F, Manktelow E et al. Natural regulation of immunity to minor histocompatibility antigens. J Immunol 2007; 178: 3558-3565.
10. Rufer N, Wolpert E, Helg C, Tiercy JM, Gratwohl A, Chapuis B et al HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation. Transplantation 1998; 66: 910-916.
11. Kollgaard T, Petersen SL, Reker S, Masmas TN, Seremet T, Andersen MH et al. Evidence for involvement of clonally expanded CD8+ T cells in anti-cancer immune responses in CLL patients following nonmyeloablative conditioning and hematopoietic cell transplantation (HCT). Leukemia 2005; 19: 2273-2280.
12. Verdijk RM, Kloosterman A, Pool J, van de KM, Naipal AM, van Halteren AG et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: Implications for stem cell transplantation and immunotherapy. Blood 2004; 103: 1961-1964.
13. Piper KP, McLarnon A, Arrazi J, Horlock C, Ainsworth J, Kilby MD et al. Functional HY-specific CD8+ T cells are found in a high proportion of women following pregnancy with a male fetus. Biol Reprod 2007; 76: 96-101.
14. James E, Chai JG, Dewchand H, Macchiarulo E, Dazzi F, Simpson E. Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. Blood 2003; 102: 388-393.
15. Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med 1999; 5: 839-842.
16. Wang W, Meadows LR, den Haan JM, Sherman NE, Chen Y, Blokland E et al Human H-Y: A male-specific histocompatibility antigen derived from the SMCY protein. Science 1995; 269: 1588-1590.
17. Chen W, McCluskey J. Immunodominance and immunodomination: Critical factors in developing effective CD8+ T-cell-based cancer vaccines. Adv Cancer Res 2006; 95: 203-247.
18. Hambach L, Spierings E, Goulmy E. Risk assessment in haematopoietic stem cell transplantation: Minor histocompatibility antigens. Best Pract Res Clin Haematol 2007; 20: 171-187.
19. Cai J, Lee J, Jankowska-Gan E, Derks R, Pool J, Mutis T et al. Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med 2004; 199: 1017-1023.
20. Gratwohl A, Hermans J, Niederwieser D, van BA, van Houwelingen HC, Apperley J. Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Hematol J 2001; 2: 363-370.
21. Gale RP, Bortin MM, van Bekkum DW, Biggs JC, Dicke KA, Gluckman E et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1987; 67: 397-406.
22. Molitor ML, Burlingham WJ. Immunobiology of exposure to non-inherited maternal antigens. Front Biosci 2007; 12: 3302-3311.